Showing results (181-190 of 366) with videos related to
Sort By:
Pageof 37
Scientific Reports|February 19, 2020
The kinase polypharmacology landscape of clinical PARP inhibitorsAlbert A Antolin, Malaka Ameratunga, Udai Banerji, et al.Pharmacotherapy|November 13, 2004
Work-related outcomes after a myocardial infarctionChristopher R McBurney, Kim A Eagle, Eva M Kline-Rogers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft modelsUdai Banerji, Michael Walton, Florence Raynaud, et al.Bioorganic & Medicinal Chemistry|December 23, 2008
Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs)Stephen Gorsuch, Vassilios Bavetsias, Martin G Rowlands, et al.Plos One|September 18, 2012
Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitorsSwee Y Sharp, S Mark Roe, Egidijus Kazlauskas, et al.Assay and Drug Development Technologies|June 24, 2005
Solid-phase immunoassays in mechanism-based drug discovery: their application in the development of inhibitors of the molecular chaperone heat-shock protein 90Anthea Hardcastle, Kathy Boxall, Juliet Richards, et al.Journal of Biomolecular Screening|February 12, 2010
Detection of the ATPase activity of the molecular chaperones Hsp90 and Hsp72 using the TranscreenerTM ADP assay kitMartin Rowlands, Craig McAndrew, Chris Prodromou, et al.Cell Cycle (Georgetown, Tex.)|April 8, 2010
Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?Marissa V Powers, Keith Jones, Caterina Barillari, et al.American Journal of Pharmaceutical Education|July 20, 2021
The Impact of an Early Clinical Experience on Pharmacy Student Learning About Ambulatory Care PracticeEmily J Ashjian, Steven R Erickson, Paul C Walker, et al.Nature Reviews. Drug Discovery|July 23, 2016
Drug discovery in advanced prostate cancer: translating biology into therapyTimothy A Yap, Alan D Smith, Roberta Ferraldeschi, et al.Pageof 37